株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

網膜中心静脈閉塞症:世界の治験動向

Central Retinal Vein Occlusion Global Clinical Trials Review, H2, 2016

発行 GlobalData 商品コード 338375
出版日 ページ情報 英文 83 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.37円で換算しております。
Back to Top
網膜中心静脈閉塞症:世界の治験動向 Central Retinal Vein Occlusion Global Clinical Trials Review, H2, 2016
出版日: 2016年12月21日 ページ情報: 英文 83 Pages
概要

当レポートでは、網膜中心静脈閉塞症の治験 (臨床試験) に関する最新動向について分析しており、地域別の治験件数、治験の段階別進行状況、被験者採用の状況、有望なスポンサー、各企業や研究機関における研究の進行状況、有望な薬剤の比較といった情報をまとめています。

イントロダクション

  • 網膜中心静脈閉塞症
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要国における治験件数
    • 中南米の主要国における治験件数

G7諸国での治験件数:眼科疾患治療薬の治験における網膜中心静脈閉塞症の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:眼科疾患治療薬の治験における網膜中心静脈閉塞症の割合

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

網膜中心静脈閉塞症治療薬の治験に携わっている主要企業

有望な薬剤

治験のプロファイル

  • 主要企業の治験の概要
    • Novartis AG
    • F. Hoffmann-La Roche Ltd.
    • Regeneron Pharmaceuticals, Inc.
    • Bayer AG
    • Allergan Plc
    • Mid Atlantic Retina
    • Jaguar Holding Company II
    • Gene Signal International SA
    • California Retina Consultants
    • Asociacion para Evitar la Ceguera en Mexico I.A.P.
  • 代表的な研究機関・病院の治験の概要
    • Shahid Beheshti University of Medical Sciences
    • Banco de Olhos de Sorocaba
    • Centre Hospitalier Intercommunal Creteil
    • Duke University
    • Eye Laser Surgery Center
    • Gazi University
    • Glostrup University Hospital
    • Greater Houston Retina Research
    • Het Oogziekenhuis Rotterdam
    • IRCCS Fondazione G.B. Bietti per lo Studio e la Ricerca in Oftalmologia ONLUS

5つの代表的な治験のプロファイル

付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC4011CTIDB

GlobalData's clinical trial report, "Central Retinal Vein Occlusion Global Clinical Trials Review, H2, 2016" provides an overview of Central Retinal Vein Occlusion clinical trials scenario. This report provides top line data relating to the clinical trials on Central Retinal Vein Occlusion. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Central Retinal Vein Occlusion to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Central Retinal Vein Occlusion to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Central Retinal Vein Occlusion Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
  • Source

List of Tables

  • Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Region, 2016*
  • Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Central Retinal Vein Occlusion Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016*
  • Central Retinal Vein Occlusion Therapeutics Clinical Trials, Europe, Top Five Countries, 2016*
  • Central Retinal Vein Occlusion Therapeutics Clinical Trials, North America, Top Countries, 2016*
  • Central Retinal Vein Occlusion Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016*
  • Central Retinal Vein Occlusion Therapeutics Clinical Trials, Central and South America, Top Countries, 2016*
  • Proportion of Central Retinal Vein Occlusion to Ophthalmology Clinical Trials, G7 Countries (%), 2016*
  • Central Retinal Vein Occlusion Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Central Retinal Vein Occlusion Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Central Retinal Vein Occlusion to Ophthalmology Clinical Trials, E7 Countries (%), 2016*
  • Central Retinal Vein Occlusion Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Phase, 2016*
  • Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials In Progress by Phase 2016*
  • Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Central Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016*
  • Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*

List of Figures

  • Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Region (%), 2016*
  • Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Central Retinal Vein Occlusion Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016*
  • Central Retinal Vein Occlusion Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016*
  • Central Retinal Vein Occlusion Therapeutics Clinical Trials, North America, Top Countries (%), 2016*
  • Central Retinal Vein Occlusion Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016*
  • Central Retinal Vein Occlusion Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016*
  • Proportion of Central Retinal Vein Occlusion to Ophthalmology Clinical Trials, G7 Countries (%), 2016*
  • Central Retinal Vein Occlusion Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Central Retinal Vein Occlusion Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Central Retinal Vein Occlusion to Ophthalmology Clinical Trials, E7 Countries (%), 2016*
  • Central Retinal Vein Occlusion Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Phase (%), 2016*
  • Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials In Progress by Phase, 2016*
  • Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Central Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016*
  • Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*
  • GlobalData Methodology
Back to Top